XML 23 R10.htm IDEA: XBRL DOCUMENT
v3.25.1

BALANCE SHEET COMPONENTS | 12 Months Ended
--- | ---
Dec. 31, 2024
BALANCE SHEET COMPONENTS |
BALANCE SHEET COMPONENTS | 4. BALANCE SHEET COMPONENTS Inventories The Company had the following major classes of inventory: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31,
​ | ​ | 2024 |  | 2023
​ |  | ​ | ​ | As Restated*
Raw Materials | ​ | $ | 569,824 | ​ | $ | 685,801
Work in Process | ​ |  | 502,525 | ​ |  | 838,871
Finished Goods | ​ |  | 1,964,870 | ​ |  | 1,851,145
Inventories | ​ | $ | 3,037,219 | ​ | $ | 3,375,817
* See Note 12 – Restatement of Previously Issued financial information for details. ​ Property and equipment - net ​ The Company’s Property and equipment - net, consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Depreciation/
​ | ​ | December 31 | ​ | Amortization
​ |  | 2024 |  | 2023 |  | Period
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Furniture and fixtures | ​ | $ | 1,453,623 | ​ | $ | 1,462,778 |  | 7 years
Equipment and computers | ​ |  | 5,491,048 | ​ |  | 5,404,743 |  | 3 to 7 years
Leasehold improvements | ​ |  | 6,282,710 | ​ |  | 6,224,863 |  | Lesser of term of lease or estimated useful life
​ | ​ |  | 13,227,381 | ​ |  | 13,092,384 |  |
Less accumulated depreciation and amortization | ​ |  | 4,224,998 | ​ |  | 3,036,030 |  |
Property and Equipment, Net | ​ | $ | 9,002,383 | ​ | $ | 10,056,354 |  |
​ Depreciation expense for the years ended December 31, 2024 and 2023, amounted to $1,341,262 and $1,239,600, respectively. Other assets ​ Other assets consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ |  | 2024 |  | 2023
​ | ​ | ​ | ​ | ​ | ​ | ​
Patent applications pending | ​ | $ | 1,612,118 | ​ | $ | 1,945,532
Patents issued | ​ | ​ | 3,390,768 | ​ | ​ | 2,982,253
Less accumulated amortization of patents issued | ​ |  | (1,254,850) | ​ |  | (1,021,233)
Patents, net | ​ |  | 3,748,036 | ​ |  | 3,906,552
Other | ​ |  | 22,644 | ​ |  | 52,051
Other Assets | ​ | $ | 3,770,680 | ​ | $ | 3,958,603
​ Patent amortization expense amounted to $235,146, and $222,836 for the years ended December 31, 2024 and 2023, respectively. ​ Patent amortization expense for the next five years and thereafter is scheduled as follows: ​
​ | ​ | ​ | ​
2025 |  | $ | 253,622
2026 | ​ |  | 252,481
2027 | ​ |  | 246,956
2028 | ​ |  | 234,087
2029 | ​ |  | 234,087
Thereafter | ​ | ​ | 914,685
Scheduled amortization of patents issued | ​ | $ | 2,135,918
​ Accrued expenses and other current liabilities ​ Accrued expenses and other current liabilities consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ | ​ | 2024 |  | 2023
​ |  | ​ | ​ | As Restated
Accrued salaries and commissions | ​ | $ | 3,387,675 | ​ | $ | 3,344,080
Professional fees | ​ | ​ | 769,577 | ​ | ​ | 956,432
Clinical studies | ​ |  | 589,577 | ​ |  | 686,908
Deferred revenue | ​ |  | 419,331 | ​ |  | 1,380,821
Other | ​ |  | 865,510 | ​ |  | 991,545
Accrued expenses and other current liabilities | ​ | $ | 6,031,670 | ​ | $ | 7,359,786
* See Note 12 – Restatement of Previously Issued financial information for details.

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration